Meet the IMPACT team
Becky worked at the Queen Elizabeth Hospital on commercial and academic trials for 5 years. She moved to the CRCTU at the University of Birmingham in 2011 to work on haematology clinical trials. Becky feels the greatest success is when a trial changes practice and has real impact on patients’ lives. She is passionate about accelerating trials to help as many patients as possible.
Rebecca has worked in research roles at Aston University, MAC Clinical Research, the University of Maryland and John Hopkins University. She started working on IMPACT in April 2020. Rebecca finds the direct correlation between the work the team puts in and the effect it has on Haematology research and patient treatment options especially fulfilling. She enjoys challenging the status quo and bringing high quality trials to NHS patients faster.
Sarah joined the CRCTU in 2015 following completion of a BSc (Hons) in Biology. After a short time in the Children’s Team, she worked in the Early Drug Development Team specialising in Phase I/II trials, including an international adult and paediatric dose finding trial for ALL and the largest precision medicine trial in NSCLC globally, the National Lung Matrix Trial. Sarah moved over to the IMPACT team in March 2022 and is excited to expand into working on stem cell transplant trials to discover the best treatment options for patients.
Steph worked at the Queen Elizabeth Hospital in Oncology Research as a Data Manager and Clinical Trials Co-ordinator for over 2 years before joining the IMPACT Team in May 2022. Steph finds it fulfilling being a part of research that has the potential to improve patient’s lives.
While completing her BSc in Biomedical Science at the University of Birmingham, Georgia learned the importance of robust research development, innovation in cancer care and clinical trials. Since joining the team in November 2022, she has felt proud to assist in the rapid delivery of efficient, novel haematology and stem cell transplant trials. Working for IMPACT aligns with her interest in bench to bedside research and she enjoys working within such a motivated team.
Gabrielle joined the CRCTU in May 2022 with a background in molecular research. After gaining an MRes in 2018 from UoB, she proceeded to work as a research technician at the IMSR in the Medical School. Here her research focused on the genetic heterogeneity of the rare adrenal cancer known as ACC. This role emphasised to Gabrielle how important innovation is in clinical research and motivated her to transition from the lab into clinical trials, where her work would directly impact patient therapy. She is extremely excited and proud to be working for the IMPACT network.
Andrea gained a PhD in the genetics of Type I diabetes from the University of Plymouth and then established her own laboratory research team in the University of Plymouth Faculty of Medicine and Dentistry. She moved to IMPACT in 2017 and finds the most fulfilling part of her role guiding a trial to conclusion, providing results that can change the future of treatment for patients. Andrea’s role provides the structure necessary to deliver transplant trials and she feels IMPACT is like a family working together to achieve the same goal.
Zsofia studied Biochemistry at the University of Bristol and is currently doing a part-time Masters in Genomic Medicine at Imperial College London. She joined the CRCTU April 2023 after previously working on Covid-19 vaccine trials at Southmead Hospital Bristol. Zsofia is looking forward to working on the RATinG trial and see the positive impact that a clinical trial can have on patient’s lives.
Vitor graduated from Bangor University with a BSc in Biomedical Sciences. Before joining the CRCTU team in June 2023, he worked as a senior scientist at the Rosalind Franklin Laboratory, which was created in response to the COVID-19 pandemic. He joined the project in its early stages and played a key role in getting the laboratory ready. Vitor is proud to be working in clinical trials that have the potential to help patients and improve their lives.
Sarah found her passion for working in Haematology whilst training as an Adult Nurse in 2016. She has worked in Haematology for two years and as an IMPACT Research Nurse for one year at King’s College Hospital in London. Sarah loves building a rapport with her patients and finds great satisfaction in improving patients’ lives by investigating new treatments through IMPACT trials.
Sally worked on the Clinical Haematology Ward at Churchill Hospital in Oxford for 6 years, gaining experience in bone marrow transplantation and general haematology. She later moved to haematology clinical trials and started her role with IMPACT in 2021. Sally is very excited to be a part of the IMPACT team and the expanding portfolio of clinical trials in bone marrow transplantation, an area which has been neglected in the past. She hopes this will lead to great advances in the future.
Deimante has worked in research since 2018 and is currently the IMPACT-funded Team Lead for Bone Marrow Transplant Trials at UCLH. Deimante joined IMPACT in 2020 and is pivotal to the setup of trials at site, screening and recruiting patients as well as conducting protocol related assessments. She enjoys educating others about clinical trials and helping dispel common myths. Patient safety is at the heart of everything Deimante does and she works closely with a multidisciplinary team to ensure patients receive holistic care beyond the requirements of IMPACT trials.
Sarah qualified in 2013 and has worked in haematology for 6 years. She joined IMPACT in 2018, working on IMPACT trials at Newcastle Freeman Hospital.